These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19230185)

  • 21. Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.
    Agger EM; Rosenkrands I; Olsen AW; Hatch G; Williams A; Kritsch C; Lingnau K; von Gabain A; Andersen CS; Korsholm KS; Andersen P
    Vaccine; 2006 Jun; 24(26):5452-60. PubMed ID: 16675077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis.
    Campuzano J; Aguilar D; Arriaga K; León JC; Salas-Rangel LP; González-y-Merchand J; Hernández-Pando R; Espitia C
    Vaccine; 2007 May; 25(18):3722-9. PubMed ID: 17399860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
    Kamath AT; Rochat AF; Valenti MP; Agger EM; Lingnau K; Andersen P; Lambert PH; Siegrist CA
    PLoS One; 2008; 3(11):e3683. PubMed ID: 18997860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB; Plikaytis BB; Shinnick TM
    Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis.
    Leemans JC; Florquin S; Heikens M; Pals ST; van der Neut R; Van Der Poll T
    J Clin Invest; 2003 Mar; 111(5):681-9. PubMed ID: 12618522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.
    Sereinig S; Stukova M; Zabolotnyh N; Ferko B; Kittel C; Romanova J; Vinogradova T; Katinger H; Kiselev O; Egorov A
    Clin Vaccine Immunol; 2006 Aug; 13(8):898-904. PubMed ID: 16893990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
    Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP
    Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.
    Shurygina AP; Zabolotnykh N; Vinogradova T; Khairullin B; Kassenov M; Nurpeisova A; Sarsenbayeva G; Sansyzbay A; Vasilyev K; Buzitskaya J; Egorov A; Stukova M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model.
    Grover A; Ahmed MF; Verma I; Sharma P; Khuller GK
    Protein Expr Purif; 2006 Aug; 48(2):274-80. PubMed ID: 16716602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats.
    Domingo M; Gil O; Serrano E; Guirado E; Nofrarias M; Grassa M; Cáceres N; Pérez B; Vilaplana C; Cardona PJ
    Scand J Immunol; 2009 Jun; 69(6):500-7. PubMed ID: 19439010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
    Cardona PJ; Amat I; Gordillo S; Arcos V; Guirado E; Díaz J; Vilaplana C; Tapia G; Ausina V
    Vaccine; 2005 Feb; 23(11):1393-8. PubMed ID: 15661388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis].
    Azaev MSh; Lebedev LR; Kuz'micheva GA; Tumanov IuV; Donchenko NA; Tat'kov SI; Nosareva OV; Il'ichev AA
    Probl Tuberk Bolezn Legk; 2007; (2):38-42. PubMed ID: 17419334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli.
    Brun P; Zumbo A; Castagliuolo I; Delogu G; Manfrin F; Sali M; Fadda G; Grillot-Courvalin C; Palù G; Manganelli R
    Vaccine; 2008 Apr; 26(16):1934-41. PubMed ID: 18342411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tuberculosis antigen ESAT-6 in Nicotiana tabacum using a potato virus X-based vector.
    Zelada AM; Calamante G; de la Paz Santangelo M; Bigi F; Verna F; Mentaberry A; Cataldi A
    Tuberculosis (Edinb); 2006; 86(3-4):263-7. PubMed ID: 16644283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.